Cargando…

Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study

Purpose: The aim of the present study was to determine whether de-escalation guided by blood cultures for patients with a diagnosis of sepsis, severe sepsis or septic shock reduces mortality, and antimicrobial drug resistance (ADR). Methods: A prospective, single-center, cohort study was conducted w...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedroso, José Victor de Miranda, Motter, Fabiane Raquel, Koba, Sonia Tiemi, Camargo, Mayara Costa, de Toledo, Maria Inês, Del Fiol, Fernando de Sá, Silva, Marcus Tolentino, Lopes, Luciane Cruz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907639/
https://www.ncbi.nlm.nih.gov/pubmed/33643032
http://dx.doi.org/10.3389/fphar.2020.576849
_version_ 1783655540816084992
author Pedroso, José Victor de Miranda
Motter, Fabiane Raquel
Koba, Sonia Tiemi
Camargo, Mayara Costa
de Toledo, Maria Inês
Del Fiol, Fernando de Sá
Silva, Marcus Tolentino
Lopes, Luciane Cruz
author_facet Pedroso, José Victor de Miranda
Motter, Fabiane Raquel
Koba, Sonia Tiemi
Camargo, Mayara Costa
de Toledo, Maria Inês
Del Fiol, Fernando de Sá
Silva, Marcus Tolentino
Lopes, Luciane Cruz
author_sort Pedroso, José Victor de Miranda
collection PubMed
description Purpose: The aim of the present study was to determine whether de-escalation guided by blood cultures for patients with a diagnosis of sepsis, severe sepsis or septic shock reduces mortality, and antimicrobial drug resistance (ADR). Methods: A prospective, single-center, cohort study was conducted with adults admitted to the ICU with a diagnosis of sepsis, severe sepsis, or septic shock at a public hospital in Sorocaba, State of São Paulo, Brazil, from January 2013 to December 2013. We excluded patients who had negative blood cultures. Patients who had replaced the initial empirical broad-spectrum antibiotic therapy (EAT) by the antibiotic therapy guided by blood cultures were compared with those who continued receiving EAT. The outcome included mortality and antimicrobial drug resistance. We used the Cox regression (proportional hazards regression) and the Poisson regression to analyze the association between antibiotic therapy guided by blood cultures (ATGBC) and outcomes. The statistical adjustment in all models included the following variables: sex, age, APACHE II (Acute Physiology And Chronic Health Evaluation II) score and SOFA (Sequential Organ Failure Assessment) score. Results: Among the 686 patients who were admitted to the intensive care unit, 91 were included in this study. The mean age of the patients was 52.7 years (standard deviation = 18.5 years) and 70.3% were male. EAT was replaced by ATGBC in 33 patients (36.3%) while 58 patients (63.7%) continued receiving EAT. Overall hospital mortality decreased from 56.9% in patients who received EAT to 48.5% in patients who received ATGBC [Hazard ratio- HR 0.44 (95% CI 0.24–0.82), p = 0.009]. There was no association between ATGBC and ADR [HR 0.90 (95% CI 0.78 – 1.03) p = 0.15]. Conclusions: Although the early and appropriate empirical EAT is undoubtedly an important factor prognostic, ATGBC can reduce the mortality in these patients.
format Online
Article
Text
id pubmed-7907639
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79076392021-02-27 Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study Pedroso, José Victor de Miranda Motter, Fabiane Raquel Koba, Sonia Tiemi Camargo, Mayara Costa de Toledo, Maria Inês Del Fiol, Fernando de Sá Silva, Marcus Tolentino Lopes, Luciane Cruz Front Pharmacol Pharmacology Purpose: The aim of the present study was to determine whether de-escalation guided by blood cultures for patients with a diagnosis of sepsis, severe sepsis or septic shock reduces mortality, and antimicrobial drug resistance (ADR). Methods: A prospective, single-center, cohort study was conducted with adults admitted to the ICU with a diagnosis of sepsis, severe sepsis, or septic shock at a public hospital in Sorocaba, State of São Paulo, Brazil, from January 2013 to December 2013. We excluded patients who had negative blood cultures. Patients who had replaced the initial empirical broad-spectrum antibiotic therapy (EAT) by the antibiotic therapy guided by blood cultures were compared with those who continued receiving EAT. The outcome included mortality and antimicrobial drug resistance. We used the Cox regression (proportional hazards regression) and the Poisson regression to analyze the association between antibiotic therapy guided by blood cultures (ATGBC) and outcomes. The statistical adjustment in all models included the following variables: sex, age, APACHE II (Acute Physiology And Chronic Health Evaluation II) score and SOFA (Sequential Organ Failure Assessment) score. Results: Among the 686 patients who were admitted to the intensive care unit, 91 were included in this study. The mean age of the patients was 52.7 years (standard deviation = 18.5 years) and 70.3% were male. EAT was replaced by ATGBC in 33 patients (36.3%) while 58 patients (63.7%) continued receiving EAT. Overall hospital mortality decreased from 56.9% in patients who received EAT to 48.5% in patients who received ATGBC [Hazard ratio- HR 0.44 (95% CI 0.24–0.82), p = 0.009]. There was no association between ATGBC and ADR [HR 0.90 (95% CI 0.78 – 1.03) p = 0.15]. Conclusions: Although the early and appropriate empirical EAT is undoubtedly an important factor prognostic, ATGBC can reduce the mortality in these patients. Frontiers Media S.A. 2021-02-12 /pmc/articles/PMC7907639/ /pubmed/33643032 http://dx.doi.org/10.3389/fphar.2020.576849 Text en Copyright © 2021 Pedroso, Motter, Koba, Camargo, Toledo, Del Fiol, Silva and Lopes. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Pedroso, José Victor de Miranda
Motter, Fabiane Raquel
Koba, Sonia Tiemi
Camargo, Mayara Costa
de Toledo, Maria Inês
Del Fiol, Fernando de Sá
Silva, Marcus Tolentino
Lopes, Luciane Cruz
Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study
title Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study
title_full Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study
title_fullStr Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study
title_full_unstemmed Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study
title_short Feasibility of De-Escalation Implementation for Positive Blood Cultures in Patients With Sepsis: A Prospective Cohort Study
title_sort feasibility of de-escalation implementation for positive blood cultures in patients with sepsis: a prospective cohort study
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907639/
https://www.ncbi.nlm.nih.gov/pubmed/33643032
http://dx.doi.org/10.3389/fphar.2020.576849
work_keys_str_mv AT pedrosojosevictordemiranda feasibilityofdeescalationimplementationforpositivebloodculturesinpatientswithsepsisaprospectivecohortstudy
AT motterfabianeraquel feasibilityofdeescalationimplementationforpositivebloodculturesinpatientswithsepsisaprospectivecohortstudy
AT kobasoniatiemi feasibilityofdeescalationimplementationforpositivebloodculturesinpatientswithsepsisaprospectivecohortstudy
AT camargomayaracosta feasibilityofdeescalationimplementationforpositivebloodculturesinpatientswithsepsisaprospectivecohortstudy
AT detoledomariaines feasibilityofdeescalationimplementationforpositivebloodculturesinpatientswithsepsisaprospectivecohortstudy
AT delfiolfernandodesa feasibilityofdeescalationimplementationforpositivebloodculturesinpatientswithsepsisaprospectivecohortstudy
AT silvamarcustolentino feasibilityofdeescalationimplementationforpositivebloodculturesinpatientswithsepsisaprospectivecohortstudy
AT lopeslucianecruz feasibilityofdeescalationimplementationforpositivebloodculturesinpatientswithsepsisaprospectivecohortstudy